Even after decades of research, there is no cure for the disease HIV causes, AIDS. But lenacapavir, born out of research on ...

Dolutegravir is an HIV integrase strand transfer inhibitor (INSTI) that does not require pharmacokinetic boosting, has a long half-life allowing for once-daily dosing in treatment-naive patients ...

Long-acting injectable antiretroviral therapy (ART) can be administered at home to persons living with HIV as safely and ...

The Trump administration's cuts to HIV prevention will lead to new infections, medical costs and death, experts warn.

In a nutshell Drugs commonly used to treat HIV and hepatitis B (called NRTIs) were found to reduce the risk of developing ...

Researchers at UVA Health are urging for clinical trials to explore whether certain HIV medications, known as nucleoside ...

South Africa’s government said its HIV-AIDS treatment program is fully funded for the current financial year despite the ...

It may result from several classes of HIV drugs, including NRTIs, NNRTIs, and PIs. Liver damage may include inflammation, death of liver cells, or too much fat in the liver. Treatment of liver ...

"We just give them drugs. We're not taking care of the ... Mary says that clinic is so overburdened by all the HIV patients who lost treatment when the U.S. cut aid, she's afraid they won't ...

"I remember seeing results from the first lenacapavir treatment study and thinking ... Keeping the people most in need of HIV drugs at the center of the PURPOSE trials, as Das did, was possible ...

One way to protect yourself from HIV is to stop injecting drugs. You can get help for substance use disorder from a doctor, counselor, or community treatment program. If you can’t stop injecting ...

She's lost access to her HIV treatment and feels weak ... Right now, she has a few pills and has decided to take them every third day. It's risky because her body could develop resistance to ...